Results 1 to 10 of about 447,491 (216)
BMC Musculoskeletal Disorders, 2021 Background Like with all cancers, multidisciplinary team (MDT) meetings are the norm in bone and soft tissue tumour (BST) management too. Problem in attendance of specialists due to geographical location is the one of the key barriers to effective ...
Raja Bhaskara Rajasekaran +4 more
doaj +1 more source
Immunotherapy in soft-tissue sarcoma.
Current Oncology, 2020 Soft-tissue sarcoma (sts) is a rare mesenchymal malignancy that accounts for less than 1% of all adult tumours. Despite the successful advancement of localized therapies such as surgery and radiotherapy, these tumours can, for many, recur-often with ...
O. Ayodele, A. Razak
semanticscholar +1 more source
Targeting glutamine metabolism slows soft tissue sarcoma growth
Nature Communications, 2020 Tumour cells frequently utilize glutamine to meet bioenergetic and biosynthetic demands of rapid cell growth. However, glutamine dependence can be highly variable between in vitro and in vivo settings, based on surrounding microenvironments and complex ...
Pearl Lee +12 more
semanticscholar +1 more source
Journal of Orthopaedic Surgery and Research, 2019 Background Osteosarcoma is the most common primary malignant bone tumor in adults and is usually located in the long bones. Standard treatment consists of perioperative chemotherapy and radical surgical resection.
Tomasz Goryń +5 more
doaj +1 more source
Radiology and Oncology, 2021 Standard therapy for localised, resectable high risk soft tissue sarcomas consists of wide excision and radiotherapy over several weeks. This treatment schedule is hardly feasible in geriatric and frail patients.
Potkrajcic Vlatko +7 more
doaj +1 more source
Wyniki leczenia operacyjnego chorych na chrzęstniakomięsaki miednicy z oszczędzeniem kończyny
Nowotwory, 2021 Analizie poddano 53 kolejnych chorych na chondrosarcoma (ChSa) kości miednicy i kości krzyżowej leczonych operacyjnie w Klinice Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowego Instytutu Onkologii im.
Andrzej Pieńkowski +9 more
doaj +1 more source
Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
World Journal of Surgical Oncology, 2019 Background The eighth edition of the American Joint Committee on Cancer (AJCC) staging system has been effective since January 2018. It has introduced some major changes in the localized/locoregional melanoma classification.
Pawel Teterycz +3 more
doaj +1 more source
Advances in the management of gastrointestinal stromal tumors (GISTs)
Nowotwory, 2020 Gastrointestinal stromal tumors are rare neoplasms developing from cells of Cajal in the gastrointestinal tract. The mainstay of such tumors treatment is surgery, whenever possible. The therapeutic management of inoperable and metastatic disease is based
Monika Dudzisz-Śledź, Piotr Rutkowski
doaj +1 more source
Diagnostic Value of Serum LncRNAs for Bone Metastasis in Lung Cancer
Zhongliu Fangzhi Yanjiu, 2022 Objective To investigate the expression of lncRNA HOTAIR, HOTAIR, CRNDE and AFAP1-AS1 in lung cancer patients with bone metastasis (LCWBM), and to elucidate the diagnostic value of lncRNAs for LCWBM. Methods Serum was collected from 38 LCWBM patients and
ZHANG Peng +5 more
doaj +1 more source
Current advances in radiotherapy for soft tissue sarcomas
Nowotwory, 2020 Radiotherapy (RT) is a part of the routine treatment of locally advanced or high-grade soft-tissue sarcomas (STS). However, RT has changed significantly over the last 20 years. Modern RT techniques have extended its potential application in STS treatment.
Mateusz J. Spałek, Aneta M. Borkowska
doaj +1 more source